Come up with a name for your new list and we'll add to it:
Avalanche Biotechnologies raised a round of funding on October 01, 2012. Investors include
National Eye Institute.
Founded in 2006, Avalanche is a publicly traded (AAVL) biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related …